Cyient DLM Ltd

- FY '27 is expected to see a strong year-over-year growth in revenue, underpinned by a strong order book and a healthy sales pipeline (~$0.5 billion). - Management projects around 25% year-on-year revenue growth for FY '27, targeting roughly INR 1,600 crores in revenue. - Operating leverage benefits are anticipated as volumes increase, potentially improving EBITDA margins beyond the current double-digit level (around 10-11%). - Altek acquisition growth is expected to contribute positively in FY '27, with synergies starting to materialize gradually. - Margins are expected to sustain at double-digit levels, with potential for improvement as scale and cross-business synergies increase. - The company is focused on tight control over operating expenses and improving working capital efficiency, which should support profitability. - No exact earnings or EPS guidance provided, but management expresses confidence in sustained profitable growth and improving profitability in FY '27 and beyond.

- Current executable order book is strong and solid for FY '27, consisting solely of confirmed purchase orders from customers. - Order book typically covers 18-24 months, meaning revenue conversion spans multiple financial years. - Order intake percentage between FY '25 and FY '26 recovered to be at or above competitor levels (35%-40% growth). - Sales pipeline is robust, with a sales pipeline close to $0.5 billion currently in negotiation. - Altek acquisition order book operates with shorter book-to-ship cycles, adding near-term revenue. - Management expects order inflows and conversion to revenue to improve starting from next quarter (Q1 FY '27). - No intercompany orders; all orders are customer-driven. - Some deferrals in execution due to external issues (West Asia war, supply chain delays) but expected to normalize in FY '27. - The company is confident of strong order intake translating into revenue growth for FY '27 and beyond.

- The company has fully utilized its IPO proceeds as of March 2025, with the account closed and compliant with the objects defined during the IPO. - There is no specific mention of any immediate or planned new fundraising through equity or debt in the latest discussions. - The management continues to focus on organic and opportunistic inorganic growth through acquisitions, based on market fit and opportunities. - No explicit guidance or plans for raising new debt or equity were disclosed in the presented conversations.

- The company is focused on both organic and inorganic growth opportunities. - They continue to look for acquisitions opportunistically, targeting both product expansion and geographic presence. - Recent acquisition of Altek had challenges but is still central to the growth strategy. - Investments have been made in strengthening the sales team across geographies and industry verticals to increase order intake. - No specific capex or strategic investment figures were disclosed. - The company is advancing in new product areas including semiconductor equipment manufacturing and AI, indicating potential future investments there. - They expect cross-pollination benefits between Indian and U.S. businesses to improve margins once tariff issues are resolved. - No concrete guidance on capex spend, but ongoing investments in people and product innovation indicate strategic capital allocation.

- FY '27 expected to deliver strong year-over-year growth across all quarters, recovering from FY '26 softness. - Targeted 25% year-on-year growth for FY '27, aiming around INR 1,600 crores revenue. - Strong order intake and pipeline (~$0.5 billion) supporting growth prospects. - Investments in sales teams to enhance customer acquisition and order intake; more hires planned in the current quarter. - Growth not limited to aerospace & defense; expanding in non-A&D sectors and new verticals like electric vehicles. - Altek acquisition expected to contribute positively with quicker order-to-revenue conversion. - Build-to-specification engagements anticipated to scale up from FY '27 Q3/Q4 and further in FY '28. - No structural challenges; growth depends on having the right sales resources on the ground. - Operating leverage expected to improve margins slightly with volume growth.